(Q38057180)

27 August 2017

title

Renal complications of diabetes. (English)

1 reference

27 August 2017

T Z Min

1

1 reference

27 August 2017

M W Stephens

series ordinal

2

1 reference

27 August 2017

P Kumar

series ordinal

3

1 reference

27 August 2017

R A Chudleigh

series ordinal

4

1 reference

27 August 2017

publication date

31 October 2012

1 reference

27 August 2017

published in

British Medical Bulletin

1 reference

27 August 2017

volume

104

1 reference

27 August 2017

page(s)

113-127

1 reference

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

The unrecognized prevalence of chronic kidney disease in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

How reliable is estimation of glomerular filtration rate at diagnosis of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Thiazolidinedione use and bone loss in older diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Intensified glucose lowering in type 2 diabetes: time for a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Antihypertensive therapy in the presence of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDS030

21 January 2018

Identifiers

DOI

10.1093/BMB/LDS030

1 reference

27 August 2017

1 reference